Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency

Scientific integrity is a crucial component of scholarly publishing.”

BUFFALO, NY – April 10, 2026 – A new editorial perspective was published in Volume 17 of Oncotarget on April 8, 2026, titled “Oncotarget: Past, Present and Future: Trends in the publishing industry.”

Authored by the Scientific Integrity Office at Oncotarget, the editorial comprehensively analyzes the journal’s evolving approach to scientific integrity. It addresses historical challenges in scholarly publishing and discusses the necessity of modern image forensics tools to meet the most rigorous standards of scientific integrity.

The Scientific Integrity Office describes how advances in digital technologies—particularly image forensics tools such as ImageTwin and analytical platforms like Argos—have transformed the ability to detect problematic data and analyze the quality of published research. 

The editorial emphasizes that the lack of adequate image tools in the “pre-tools” era limited journals’ ability to detect image-related issues, underscoring the importance of recent technological advancements. It also highlights that Argos provides a good opportunity to obtain an objective picture across different journals in both the pre- and post-tools eras.

Looking forward, Oncotarget advocates indexes for broader adoption of independent analytical and AI-based tools in journal evaluation. In the public interest, it also encourages open discussion of how indexes select, deselect, and reevaluate journals. 

DOI: https://doi.org/10.18632/oncotarget.28852    

Correspondence to: Scientific Integrity Office at Oncotarget – scientificintegrityoffice@impactjournals.com

Click here to sign up for free Altmetric alerts about this article.

________

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

X
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Spotify
, and available wherever you listen to podcasts

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact media@impactjournals.com.

Leave a Reply

Your email address will not be published. Required fields are marked *